NCCM
BSPM

Nine Chapters Capital Management’s Biostar Pharmaceuticals, Inc. BSPM Stock Holding History

Nine Chapters Capital Management’s Portfolio BSPM Stock Details BSPM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-8,386
Closed -$61K – 1328
2015
Q2 		$61K Buy
+8,386
New +$75.1K 0.01% 904

Other funds holding BSPM

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Nine Chapters Capital Management's BSPM Position: Q3 2015 in Review

Nine Chapters Capital Management sold out of Biostar Pharmaceuticals, Inc. (BSPM) in Q3 2015, closing a stake of 8,386 shares — an estimated $61K sold.

Nine Chapters Capital Management first reported a position in BSPM in Q2 2015 and held it in 1 quarter. The position peaked at $61K in Q2 2015. 6 funds tracked by Wall St. Rank hold BSPM as of Q3 2015.

  • Nine Chapters Capital Management reported no remaining Biostar Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 8,386 Biostar Pharmaceuticals, Inc. shares in Q3 2015, an estimated $61K.
  • Nine Chapters Capital Management first reported a position in Biostar Pharmaceuticals, Inc. in Q2 2015 and held it in 1 quarter.
  • Nine Chapters Capital Management's Biostar Pharmaceuticals, Inc. position peaked at $61K in Q2 2015.
  • 6 funds tracked by Wall St. Rank held Biostar Pharmaceuticals, Inc. as of Q3 2015.

Based on Nine Chapters Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.